from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3054c/-

LFCtreatmentdescriptionclass of inhibitor

0.094

Amikacinug/mL Amikacintranslation

0.797

Cap5-10ug/mL Capreomycintranslation

0.759

Rox10-50 ug/mL Roxithromycintranslation

0.234

SM2-5 ug/mL Streptomycintranslation

0.627

Tet5-10 ug/mL Tetracyclinetranslation

-0.341

Rif0.2-5ug/mL Rifampicintranscription

-0.668

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.563

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.162

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.309

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.848

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.369

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.318

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.622

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.445

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.551

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.780

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.458

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

2.611

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.417

KCN5-20 ug/mL Potassium cyaniderespiration

0.000

NaN30.2-2 mM Sodium aziderespiration

-0.564

Nigericin50 uM Nigericinrespiration

1.971

TRC10-150 ug/mL Triclosanrespiration

-0.480

TRZ10-25 ug/mL Thioridazinerespiration

0.759

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

3.194

menadione6-10 ug/mL Menadionerespiration

-0.443

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.584

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.167

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.719

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.405

NRP_1Non-replicating persistence stage 1dosRassociated

-0.448

Amp0.2mg/mL AmpicillincellWall

-0.616

Cephalexin20-100 ug/mL CephalexincellWall

-0.372

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.486

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.396

EMB10-20 ug/mL EthambutolcellWall

-0.470

Eta12-40 ug/mL EthionamidecellWall

-0.493

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.412

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.729

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.245

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.345

BZA0.12 mg/mL BenzamidearomaticAmides

0.262

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.777

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.149

H2O24 mM hydrogen peroxideDNAdamaging

-0.329

Levo10 ug/mL LevofloxacinDNAdamaging

-0.363

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.193

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.197

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.154

UVUV-irradiationDNAdamaging

3.607

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.859

Antimycin12.5-50 ug/mL Antimycin A?

-0.593

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.578

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.304

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.186

PA8240.2-2 ug/mL PA-824?

-0.589

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.519

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.000

Verapamil50 uM Verapamil?

-0.383

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.720

methoxatin10-20 ug/mL Methoxatin?